XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2019   10,899,210    
Balance at beginning of period at Dec. 31, 2019 $ 212,508 $ 64,073 $ 144,839 $ 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 20,159   20,159  
Net unrealized gain (loss) on securities available for sale, net of tax 1,863     1,863
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 43     43
Net unrealized gain (loss) on cash flow hedging derivative instruments, net of tax (5,897)     (5,897)
Comprehensive income (loss) 16,168   20,159 (3,991)
Cash dividend declared (10,058)   (10,058)  
Equity compensation expense 482 $ 482    
Payment to repurchase common stock (in shares)   (5,447)    
Payment to repurchase common stock (157)   (157)  
Issuance of restricted stock (in shares)   27,345    
Proceeds from sale of common stock (in shares)   21,851    
Proceeds from sale of common stock $ 497 $ 497    
Ending balance (in shares) at Sep. 30, 2020 10,942,959 10,942,959    
Balance at end of period at Sep. 30, 2020 $ 219,440 $ 65,052 154,783 (395)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 7,095      
Net unrealized gain (loss) on securities available for sale, net of tax (1,580)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 7      
Net unrealized gain (loss) on cash flow hedging derivative instruments, net of tax 387      
Comprehensive income (loss) $ 5,909      
Ending balance (in shares) at Sep. 30, 2020 10,942,959 10,942,959    
Balance at end of period at Sep. 30, 2020 $ 219,440 $ 65,052 154,783 (395)
Beginning balance (in shares) at Dec. 31, 2020 10,950,289 10,950,289    
Balance at beginning of period at Dec. 31, 2020 $ 223,726 $ 65,395 158,359 (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 26,723   26,723  
Net unrealized gain (loss) on securities available for sale, net of tax (5,636)     (5,636)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 34     34
Net unrealized gain (loss) on cash flow hedging derivative instruments, net of tax 3,395     3,395
Comprehensive income (loss) 24,516   26,723 (2,207)
Cash dividend declared (10,438)   (10,438)  
Equity compensation expense 672 $ 672    
Payment to repurchase common stock (in shares)   (10,252)    
Payment to repurchase common stock (253)   (253)  
Issuance of restricted stock (in shares)   34,689    
Proceeds from sale of common stock (in shares)   18,224    
Proceeds from sale of common stock $ 514 $ 514    
Ending balance (in shares) at Sep. 30, 2021 10,992,950 10,992,950    
Balance at end of period at Sep. 30, 2021 $ 238,737 $ 66,581 174,391 (2,235)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 9,014      
Net unrealized gain (loss) on securities available for sale, net of tax (1,817)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 14      
Net unrealized gain (loss) on cash flow hedging derivative instruments, net of tax 546      
Comprehensive income (loss) $ 7,757      
Ending balance (in shares) at Sep. 30, 2021 10,992,950 10,992,950    
Balance at end of period at Sep. 30, 2021 $ 238,737 $ 66,581 $ 174,391 $ (2,235)